Literature DB >> 2735812

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior.

E F Coccaro1, L J Siever, H M Klar, G Maurer, K Cochrane, T B Cooper, R C Mohs, K L Davis.   

Abstract

Dysfunction of the central serotonergic system has been variously associated with depression and with suicidal and/or impulsive aggressive behavior. To evaluate central serotonergic function in relation to these variables, prolactin responses to a single-dose challenge with fenfluramine hydrochloride (60 mg orally), a serotonin releasing/uptake-inhibiting agent, were examined in 45 male patients with clearly defined major affective (n = 25) and/or personality disorder (n = 20) and in 18 normal male control patients. Prolactin responses to fenfluramine among all patients were reduced compared with responses of controls. Reduced prolactin responses to fenfluramine were correlated with history of suicide attempt in all patients but with clinician and self-reported ratings of impulsive aggression in patients with personality disorder only; there was no correlation with depression. These results suggest that reduced central serotonergic function is present in a subgroup of patients with major affective and/or personality disorder and is associated with history of suicide attempt in patients with either disorder, but with impulsive aggression in patients with personality disorder only.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735812     DOI: 10.1001/archpsyc.1989.01810070013002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  104 in total

1.  Is the nature of personality disorder categoric or dimensional?

Authors:  E F Coccaro
Journal:  Curr Psychiatry Rep       Date:  2000-02       Impact factor: 5.285

2.  Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls.

Authors:  M Mercedes Perez-Rodriguez; Shauna Weinstein; Antonia S New; Laura Bevilacqua; Qiaoping Yuan; Zhifeng Zhou; Colin Hodgkinson; Marianne Goodman; Harold W Koenigsberg; David Goldman; Larry J Siever
Journal:  J Psychiatr Res       Date:  2010-05-06       Impact factor: 4.791

3.  Psychiatric symptoms in adolescence as predictors of obesity in early adulthood: a longitudinal study.

Authors:  D S Pine; P Cohen; J Brook; J D Coplan
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

Review 4.  New developments in the neurobiology of borderline personality disorder.

Authors:  Martin Bohus; Christian Schmahl; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

5.  Using Atypical Antipsychotics in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-12

6.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

7.  Citalopram intervention for hostility: results of a randomized clinical trial.

Authors:  Thomas W Kamarck; Roger F Haskett; Matthew Muldoon; Janine D Flory; Barbara Anderson; Robert Bies; Bruce Pollock; Stephen B Manuck
Journal:  J Consult Clin Psychol       Date:  2009-02

8.  The Neuropsychopharmacology of Pathological Gambling.

Authors:  Kourosh Zakeri; Marc N Potenza
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

Review 9.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

10.  5-HTTLPR and gender moderate changes in negative affect responses to tryptophan infusion.

Authors:  Beverly H Brummett; Christopher L Muller; Ann L Collins; Stephen H Boyle; Cynthia M Kuhn; Ilene C Siegler; Redford B Williams; Allison Ashley-Koch
Journal:  Behav Genet       Date:  2008-07-26       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.